Treatment of pancreatic ductal adenocarcinoma (PDAC) is extremely difficult due to its aggressive nature and limited diagnostic tools. While traditional staging systems, such as the TNM classification, focus on physical factors, they fall short of providing a comprehensive prognosis. The Tianjin grading system addresses this gap by integrating physical, biological, and patient status factors.
Please follow and like us:
